TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/1/07 16:55 | 2/28/07 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Radak John Matthew | CA | O | VP Finan | S.d | -49 | 64.28 | 0 | -1 | -30 | 2 | D | ||||||||||||||
5/17/06 20:23 | 5/15/06 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Radak John Matthew | CA | O | VP Finan | S.d | -26 | 67.05 | 0 | 0 | -18 | 2 | |||||||||||||||
8/8/05 19:35 | 8/5/05 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Radak John Matthew | CA | O | VP,Finan | S.d | -22 | 85.43 | 0 | 0 | -100 | 0 | D | ||||||||||||||
2/24/05 18:53 | 2/22/05 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Radak John Matthew | CA | O | VP Finan | S | -91 | 69.64 | 0 | -1 | -100 | 0 | D | ||||||||||||||
8/29/03 12:11 | 8/29/03 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Radak John Matthew | CA | O | VP Fina | S | -36 | 57.95 | 0 | -1 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |